Pure Global

JAWZ Endomyocardial Biopsy Forceps - Endomyocardial biopsy forceps - ARTG 482609

Access comprehensive regulatory information for JAWZ Endomyocardial Biopsy Forceps - Endomyocardial biopsy forceps in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is registered under ARTG number 482609 and sponsored by Life Healthcare Pty Ltd, manufactured by Argon Medical Devices Inc in United States of America. The device registration started on March 14, 2025.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.

Free Database
Powered by Pure Global AI
TGA ARTG Official Data
Class III
ARTG 482609
Class III
JAWZ Endomyocardial Biopsy Forceps - Endomyocardial biopsy forceps
ARTG ID: 482609
Good Name: Life Healthcare Pty Ltd - JAWZ Endomyocardial Biopsy Forceps - Endomyocardial biopsy forceps
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Intended Purpose

The JAWZ Endomyocardial Biopsy Forceps are manually operated medical devices used to collect endomyocardial tissue samples from the inner wall of the heart for histopathological examination.

Device Classification
Risk Class
Class III
Product Type
Single Device Product
ARTG Category
General
Registration Information
ARTG ID
482609
Start Date
March 14, 2025
Effective Date
March 25, 2025
Manufacturer
Country
United States of America
Address
1445 Flat Creek Road, Athens, Texas, 75751